Cargando…
MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer
BACKGROUND: Challenges in medical care posed by rapid tumor progression, individualized responses to therapy, and the heterogeneous characteristics of breast cancer (BRCA) highlight the urgent need for new treatment strategies, as well as therapeutic and prognostic markers. Accumulating evidence has...
Autores principales: | Yang, Meng, Xiao, Ran, Wang, Xinru, Xiong, Youyi, Duan, Zhenfeng, Li, Duolu, Kan, Quancheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908185/ https://www.ncbi.nlm.nih.gov/pubmed/35280383 http://dx.doi.org/10.21037/atm-22-97 |
Ejemplares similares
-
High miR-3609 expression is associated with better prognosis in TNBC based on mining using systematic integrated public sequencing data
por: Ding, Rumeng, et al.
Publicado: (2022) -
MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET
por: Han, Chao, et al.
Publicado: (2015) -
MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1
por: Bao, Chang, et al.
Publicado: (2020) -
Matrine induces cell cycle arrest and apoptosis with recovery of the expression of miR-126 in the A549 non-small cell lung cancer cell line
por: An, Qi, et al.
Publicado: (2016) -
miR-93-5p suppresses ovarian cancer malignancy and negatively regulate CCND2 by binding to its 3′UTR region
por: Chen, Guotong, et al.
Publicado: (2022)